IL-33 accelerates cutaneous wound healing involved in upregulation of alternatively activated macrophages

Molecular Immunology

Volumn 56, Issue 4, 2013, Pages 347-353

  Yin, Hui ^a   Li, Xiangyong ^b   Hu, Shilian ^a   Liu, Tao ^a   Yuan, Baohong ^a   Gu, Hongbiao ^a   Ni, Qian ^a   Zhang, Xiaofan ^a   Zheng, Fang ^c  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alternatively activated macrophages; Cytokines; IL 33; Inflammation; Wound healing

Indexed keywords

COLLAGEN; FIBRONECTIN; INTERLEUKIN 33; MESSENGER RNA; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-33, MOUSE; LECTIN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN; SCLEROPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INJURY; UPREGULATION; WOUND HEALING; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; GENETICS; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE ACTIVATION; METABOLISM; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; TIME;

ANIMALS; ANTIGENS, DIFFERENTIATION; COLLAGEN; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; INTERLEUKINS; LECTINS, C-TYPE; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED BALB C; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; TIME FACTORS; UP-REGULATION; WOUND HEALING;

EID: 84881102033     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.05.225     Document Type: Article

References (39)

1. Alves-Filho J.C., Sonego F., Souto F.O., Freitas A., Verri W.A., Auxiliadora-Martins M., Basile-Filho A., McKenzie A.N., Xu D., Cunha F.Q., Liew F.Y. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nature Medicine 2010, 16:708-712.
2. Behm B., Babilas P., Landthaler M., Schreml S. Cytokines, chemokines and growth factors in wound healing. Journal of the European Academy of Dermatology and Venereology 2012, 26:812-820.
3. Brancato S.K., Albina J.E. Wound macrophages as key regulators of repair: origin, phenotype, and function. The American Journal of Pathology 2011, 178:19-25.
4. Carriere V., Roussel L., Ortega N., Lacorre D.A., Americh L., Aguilar L., Bouche G., Girard J.P. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:282-287.
5. Cherry W.B., Yoon J., Bartemes K.R., Iijima K., Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. Journal of Allergy and Clinical Immunology 2008, 121:1484-1490.
6. Daley J.M., Brancato S.K., Thomay A.A., Reichner J.S., Albina J.E. The phenotype of murine wound macrophages. Journal of Leukocyte Biology 2010, 87:59-67.
7. DiPietro L.A. Wound healing: the role of the macrophage and other immune cells. Shock 1995, 4:233-240.
8. Duan L., Chen J., Zhang H., Yang H., Zhu P., Xiong A., Xia Q., Zheng F., Tan Z., Gong F., Fang M. IL-33 ameliorates experimental colitis through promoting Th2/Foxp3(+) Treg responses in mice. Molecular Medicine 2012, 18:753-761.
9. Eming S.A., Krieg T., Davidson J.M. Inflammation in wound repair: molecular and cellular mechanisms. Journal of Investigative Dermatology 2007, 127:514-525.
10. Fang Y., Gong S.J., Xu Y.H., Hambly B.D., Bao S. Impaired cutaneous wound healing in granulocyte/macrophage colony-stimulating factor knockout mice. British Journal of Dermatology 2007, 157:458-465.
11. Gordon S. Alternative activation of macrophages. Nature Reviews Immunology 2003, 3:23-35.
12. Haraldsen G., Balogh J., Pollheimer J., Sponheim J., Küchler A.M. Interleukin-33-cytokine of dual function or novel alarmin?. Trends in Immunology 2009, 30:227-233.
13. Iikura M., Suto H., Kajiwara N., Oboki K., Ohno T., Okayama Y., Saito H., Galli S.J., Nakae S. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Laboratory Investigation 2007, 87:971-978.
14. Komai-Koma M., Xu D., Li Y., McKenzie A.N., McInnes I.B., Liew F.Y. IL-33 is a chemoattractant for human Th2 cells. European Journal of Immunology 2007, 37:2779-2786.
15. Küchler A.M., Pollheimer J., Balogh J., Sponheim J., Manley L., Sorensen D.R., De Angelis P.M., Scott H., Haraldsen G. Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. American Journal of Pathology 2008, 173:1229-1242.
16. Louten J., Rankin A.L., Li Y., Murphy E.E., Beaumont M., Moon C., Bourne P., McClanahan T.K., Pflanz S., de Waal Malefyt R. Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation. International Immunology 2011, 23:307-315.
17. Lucas T., Waisman A., Ranjan R., Roes J., Krieg T., Müller W., Roers A., Eming S.A. Differential roles of macrophages in diverse phases of skin repair. Journal of Immunology 2010, 184:3964-3977.
18. Manetti M., Ibba-Manneschi L., Liakouli V., Guiducci S., Milia A., Benelli G., Marrelli A., Conforti M., Romano E., Giacomelli R., Matucci-Cerinic M., Cipriani P. The IL-1-like cytokine IL-33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis. Annals of the Rheumatic Diseases 2010, 69:598-605.
19. Martin P., Leibovich S.J. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends in Cell Biology 2005, 15:599-607.
20. McGrady G., Song X.Y., Wahl S.M. Tumor necrosis factor-alpha (TNF-α) is a therapeutic target for impaired cutaneous wound healing. Wound Repair and Regeneration 2012, 20:38-49.
21. McLaren J.E., Michael D.R., Salter R.C., Ashlin T.G., Calder C.J., Miller A.M., Liew F.Y., Ramji D.P. IL-33 reduces macrophage foam cell formation. Journal of Immunology 2010, 185:1222-1229.
22. Miller A.M., Xu D., Asquith D.L., Denby L., Li Y., Sattar N., Baker A.H., McInnes I.B., Liew F.Y. IL-33 reduces the development of atherosclerosis. Journal of Experimental Medicine 2008, 205:339-346.
23. Mirza R., DiPietro L.A., Koh T.J. Selective and specific macrophage ablation is detrimental to wound healing in mice. American Journal of Pathology 2009, 175:2454-2462.
24. Mori R., Kondo T., Ohshima T., Ishida Y., Mukaida N. Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB Journal 2002, 16:963-974.
25. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology 2008, 8:958-969.
26. Moussion C., Ortega N., Girard J.P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?. PLoS ONE 2008, 3:e3331.
27. Ozawa K., Kondo T., Hori O., Kitao K., Stern D.M., Eisenmenger W., Ogawa S., Ohshima T. Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport. Journal of Clinical Investigation 2001, 108:41-50.
28. Pastorelli L., Garg R.R., Hoang S.B., Spina L., Mattioli B., Scarpa M., Fiocchi C., Vecchi M., Pizarro T.T. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:8017-8022.
29. Rankin A.L., Mumm J.B., Murphy E., Turner S., Yu N., McClanahan T.K., Bourne P.A., Pierce R.H., Kastelein R., Pflanz S. IL-33 induces IL-13-dependent cutaneous fibrosis. Journal of Immunology 2010, 184:1526-1535.
30. Reinke J.M., Sorg H. Wound repair and regeneration. European Surgical Research 2012, 49:35-43.
31. Sakai N., Van Sweringen H.L., Quillin R.C., Schuster R., Blanchard J., Burns J.M., Tevar A.D., Edwards M.J., Lentsch A.B. Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice. Hepatology 2012, 56:1468-1478.
32. Salmon-Her V., Ramont L., Godeau G., Birembaut P., Guenounou M., Bernard P., Maquart F.X. Implication of interleukin-4 in wound healing. Laboratory Investigation 2000, 80:1337-1343.
33. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D.M., Bazan J.F., Kastelein R.A. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptorrelated protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
34. Smithgall M.D., Comeau M.R., Yoon B.R., Kaufman D., Armitage R., Smith D.E. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. International Immunology 2008, 20:1019-1030.
35. Straino S., Di Carlo A., Mangoni A., De Mori R., Guerra L., Maurelli R., Panacchia L., Di Giacomo F., Palumbo R., Di Campli C., Uccioli L., Biglioli P., Bianchi M.E., Capogrossi M.C., Germani A. High-mobility group box 1 protein in human and murine skin: involvement in wound healing. Journal of Investigative Dermatology 2008, 128:1545-1553.
36. Theoharides T.C., Zhang B., Kempuraj D., Tagen M., Vasiadi M., Angelidou A., Alysandratos K.D., Kalogeromitros D., Asadi S., Stavrianeas N., Peterson E., Leeman S., Conti P. IL-33 augments substance P induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:4448-4453.
37. Thomay A.A., Daley J.M., Sabo E., Worth P.J., Shelton L.J., Harty M.W., Reichner J.S., Albina J.E. Disruption of interleukin-1 signaling improves the quality of wound healing. American Journal of Pathology 2009, 174:2129-2136.
38. Yin H., Li X.Y., Jin X.B., Zhang B.B., Gong Q., Yang H., Zheng F., Gong F.L., Zhu J.Y. IL-33 prolongs murine cardiac allograft survival through induction of Th2-type immune deviation. Transplantation 2010, 89:1189-1197.
39. Yin H., Li X.Y., Yuan B.H., Zhang B.B., Hu S.L., Gu H.B., Jin X.B., Zhu J.Y. Adenovirus-mediated overexpression of soluble ST2 provides a protective effect on lipopolysaccharideinduced acute lung injury in mice. Clinical & Experimental Immunology 2011, 164:248-255.